Strongyloidiasis at the Boston City Hospital. Emphasis on gastrointestinal pathophysiology and successful therapy with thiabendazole.
D000126:Achlorhydria / Q000209:etiology*; D001706:Biopsy; D002338:Carotenoids / Q000097:blood; D002648:Child; D004064:Digestive System / Q000503:physiopathology; D004187:Disaccharides / Q000378:metabolism; D004225:Dithiazanine / Q000627:therapeutic use; D004386:Duodenum / Q000473:pathology; D005260:Female; D005492:Folic Acid / Q000097:blood; D005745:Gastric Acidity Determination; D005951:Glucose Tolerance Test; D006801:Humans; D007421:Intestine, Small / Q000378:metabolism; D007501:Iron / Q000097:blood; D008286:Malabsorption Syndromes / Q000209:etiology*; D008297:Male; D008404:Massachusetts; D008875:Middle Aged; D012546:Schilling Test; D013270:Stomach / Q000473:pathology; D013322:Strongyloidiasis / Q000150:complications / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D013827:Thiabendazole / Q000008:administration & dosage*; D014805:Vitamin B 12 / Q000097:blood
D004187:Disaccharides; D002338:Carotenoids; D004225:Dithiazanine; D005492:Folic Acid; D007501:Iron; D013827:Thiabendazole; D014805:Vitamin B 12